Targeting AAV Vectors to the CNS via De Novo Engineered Capsid-Receptor Interactions

被引：0

作者：

Huang, Qin ^{[1
]}

Chen, Albert ^{[2
]}

Chan, Ken Y. ^{[1
]}

Sorensen, Hikari ^{[1
]}

Barry, Andrew J. ^{[1
]}

Azari, Bahar ^{[3
]}

Beddow, Thomas ^{[1
]}

Zheng, Qingxia ^{[1
]}

Zhao, Binhui ^{[1
]}

Tobey, Isabelle G. ^{[1
]}

Eid, Fatma Elzahraa ^{[1
]}

Chan, Alina ^{[1
]}

Deverman, Benjamin E. ^{[1
]}

机构：

[1] Broad Inst MIT & Harvard, Cambridge, MA USA

[2] Harvard Univ, Cambridge, MA USA

[3] Northeastern Univ, Elect & Comp Engn Dept, Boston, MA USA

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

441

引用

页码：228 / 229

页数：2

共 50 条

[1] Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier
Huang, Qin
Chen, Albert T. J.
Chan, Ken Y.
Sorensen, Hikari
Barry, Andrew
Azari, Bahar
Zheng, Qingxia G.
Beddow, Thomas
Zhao, Binhui
Tobey, Isabelle J.
Moncada-Reid, Cynthia
Eid, Fatma-Elzahraa R.
Walkey, Christopher D.
Ljungberg, M. Cecilia A.
Lagor, William E.
Heaney, Jason
Chan, Yujia
Deverman, Benjamin
PLOS BIOLOGY, 2023, 21 (07)
[2] AAV-Mediated CNS-Wide Gene Delivery via a De Novo Engineered Capsid-Human Receptor Interaction
Chan, Ken Y.
Huang, Qin
Johnston, Jencilin
Barry, Andrew J.
Zheng, Qingxia
Chen, Albert T.
Beddow, Thomas
Keyes, Casey
Pacouret, Simon
Brauer, Pamela P.
Lou, Shan
Clouse, Gabrielle
Wu, Jason
Navarrete, Nuria R. R.
Eid, Fatma Elzahraa
Chan, Yujia A.
Deverman, Benjamin E.
MOLECULAR THERAPY, 2023, 31 (04) : 56 - 56
[3] In Vivo targeting of HSC by capsid-engineered AAV vectors
Meumann, N.
Radtke, S.
Garmendia, X. Perez
Just, S.
Gutierrez, A. Fornell
Ertelt, M.
Schoeder, C. T.
Kuhlmann, A. S.
Peterson, C. W.
Stone, D.
Jerome, K.
Kiem, H. P.
Buening, H.
HUMAN GENE THERAPY, 2024, 35 (3-4) : A9 - A10
[4] Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
Buning, Hildegard
Srivastava, Arun
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 12 : 248 - 265
[5] Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors
Kay, Christine N.
Ryals, Renee C.
Aslanidi, George V.
Min, Seok Hong
Ruan, Qing
Sun, Jingfen
Dyka, Frank M.
Kasuga, Daniel
Ayala, Andrea E.
Van Vliet, Kim
Agbandje-McKenna, Mavis
Hauswirth, William W.
Boye, Sanford L.
Boye, Shannon E.
PLOS ONE, 2013, 8 (04):
[6] Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid
Martino, R. Alexander
Wang, Qiang
Xu, Hao
Hu, Gui
Bell, Peter
Arroyo, Edgardo. J. J.
Sims, Joshua. J. J.
Wilson, James. M. M.
JOURNAL OF VIROLOGY, 2023, 97 (06) : e0017423
[7] Engineered AAV capsid transport mutants overcome transduction deficiencies in the aged CNS
Sandoval, Ivette M.
Kelley, Christy M.
Bernal-Conde, Luis Daniel
Steece-Collier, Kathy
Marmion, David J.
Davidsson, Marcus
Crosson, Sean M.
Boye, Sanford L.
Boye, Shannon E.
Manfredsson, Fredric P.
MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (04):
[8] Cell infection by capsid engineered AAV vectors: variations from the common scheme?
Uhrig, Silke
Perabo, Luca
Hallek, Michael
Buening, Hildegard
HUMAN GENE THERAPY, 2008, 19 (10) : 1191 - 1191
[9] The Capsid Race: Multiplexed Analysis and Comparison of Rationally Engineered AAV CNS Capsids In Vivo
Pimentel, Elena
Kieper, Sebastian
Moreno, Fiona
Van der Zon, Tom
Bosma, Bas
Bashir, Noun
Waaijer, Stijn
Espinosa, Pedro
Hoogland, Tycho
Valls, Mercedes
Pesic, Milja
Kusuma, Angga
MOLECULAR THERAPY, 2023, 31 (04) : 231 - 232
[10] Identification and validation of novel engineered AAV capsid variants targeting human glia
Giacomoni, Jessica
Akerblom, Malin
Habekost, Mette
Fiorenzano, Alessandro
Kajtez, Janko
Davidsson, Marcus
Parmar, Malin
Bjorklund, Tomas
FRONTIERS IN NEUROSCIENCE, 2024, 18

← 1 2 3 4 5 →